Sixteen temporary air film "fire eye" laboratories have been built in Zhongshan Memorial Park in Hong Kong. against the backdrop of continuing serious public health incidents in Hong Kong, they will provide 100000 tests a day for 7.5 million Hong Kong people.
Zhitong Finance has learned that 16 temporary gas film "fire eye" laboratories are built for Huacheng Diagnostic Center, which is served by Chinese biotechnology, a listed company in Hong Kong.(08037) A joint venture with Yoda Health Hong Kong Co., Ltd.
The Wah Wan Diagnostic Centre is also one of the assisted testing institutions hired by the Hong Kong SAR Government, which is mainly responsible for testing two high-risk groups of taxi drivers and residential care workers for the elderly. so far, 50,000 tests have been completed.
Data show that 16:00 on August 6, the first car of materials for the gas film "Fire Eye" laboratory was sent from Shenzhen to Hong Kong and arrived at the Zhongshan Memorial Park Gymnasium at 21:00. At 03:30 on the 7th, 16 gas film "fire eye laboratories" were completed.
Wang Shihua, special advisor to Huazhong Diagnostic Center, said that Huacheng currently has a daily inspection of 30,000 people per day, and the daily measurement can be increased to 130000 people in a short period of time. "if mixed samples are tested, 500000 samples can be tested every day."
The third wave of public health incidents, mainly local cases, has broken out in Hong Kong since July, with a total of more than 4000 confirmed cases. The proportion of cases with unknown sources accounts for about 40%, indicating that there are still many invisible patients in the community, and the risk of virus transmission is very high.
It has become an urgent task for Hong Kong to carry out universal testing as soon as possible, track the source and trajectory of the virus, and isolate patients with mild symptoms and asymptomatic symptoms.
Based on this, the Central people's Government has provided support to Hong Kong through three national testing services, including BGI, Kip Biology and Jinyu Medicine. Because of its strong detection capability and the advantage of Chinese biotechnology taking root in Hong Kong for many years, Huachi Diagnostic Center took the lead in building 16 temporary gas film "fire eye" laboratories in the Zhongshan Memorial Park Gymnasium.
In fact, since its establishment, Huacheng Diagnostic Center has received the full support of the two major shareholders of BGI and China Biotechnology Services.
Take BGI as an example, it mobilizes BGI's global and national manpower and resources to apply highly automated, professional and efficient testing technology to Hong Kong, helping to enhance the testing capability and efficiency of Hong Kong laboratories. For example, the "Fire Eye" laboratory has landed in 13 major cities across the country, such as Beijing, Wuhan, Shenzhen, Tianjin, and so on, with more than 160000 daily test fluxes; more than 90 fire eye laboratories have been built in 30 countries, including Gabon, Saudi Arabia, Togo, Lome, Kazakhstan, and so on, to help fight the global epidemic.
The construction and operation of the Hong Kong "Fire Eye Laboratory" is based on the successful experience of previous large-scale nucleic acid screening. There are laboratories that meet international standards and testing kits included in World Health Organization (WHO) 's emergency purchase list and used in more than 180 countries and regions around the world, which is sufficient to ensure the smooth implementation of universal testing in Hong Kong.
In terms of biotechnology services in China, the existing business mainly includes two major directions: accurate diagnosis (accurate large health detection system) and accurate therapy (integrated industrial chain of cell therapy). Based on Guangdong-Hong Kong-Macau Greater Bay Area, the business scope is oriented to China and radiates Europe and the United States.
Its third-party medical testing center, which was founded in 1968 and has a history of more than 50 years in Hong Kong, has high brand awareness and won ISO15189 and CAP laboratory qualifications. To provide the joint venture with Hong Kong's advanced testing and management standards, the most experienced testing talents in Hong Kong, as well as operation and management personnel.
The two sides make full use of their respective advantages to jointly empower the joint venture company Huacheng.
Zhitong Finance noted that in addition to partnering with BGI to set up the Huatou Diagnostic Center, China Biotechnology Services has also won the overseas distribution of the latter's virus testing reagents.
At present, the laboratory of Huacheng Diagnostic Center has been operated 24 hours a day. In addition to increasing automatic processing capacity, it has also independently developed test kits made and produced in Hong Kong. The aim is to provide Hong Kong people with efficient, accurate and reasonably priced testing services, so as to contribute to the successful fight against epidemic in Hong Kong as soon as possible.